ACADIA Pharmaceuticals News

ACADIA Pharmaceuticals Analyst Ratings

BenzingaApr 10 09:32 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: SAGE Therapeutics (SAGE), Apellis Pharmaceuticals (APLS) and ACADIA Pharmaceuticals (ACAD)

TipRanksApr 9 06:40 ET

ACADIA Pharmaceuticals Analyst Ratings

BenzingaApr 9 06:27 ET

Analysts Offer Insights on Healthcare Companies: Incyte (INCY), BioMarin Pharmaceutical (BMRN) and ACADIA Pharmaceuticals (ACAD)

TipRanksApr 8 22:40 ET

ACADIA Pharmaceuticals Analyst Ratings

BenzingaMar 25 09:19 ET

ACADIA Pharmaceuticals Analyst Ratings

BenzingaMar 13 12:01 ET

UBS Adjusts ACADIA Pharmaceuticals Price Target to $33 From $35, Maintains Buy Rating

MT NewswiresMar 13 11:35 ET

Morgan Stanley Cuts Price Target on ACADIA Pharmaceuticals to $30 From $40 After Failed Study of Pimavanserin in Negative Symptoms of Schizophrenia; Overweight Kept

MT NewswiresMar 13 07:18 ET

UBS Cuts Acadia Pharma Target to $33 on Nuplazid Trial Outcome

Investing.com Mar 12 16:24 ET

Mizuho Cuts Acadia to Neutral, Cites Lack of Upcoming Catalysts

Seeking AlphaMar 12 10:39 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Incyte (INCY), AbbVie (ABBV) and ACADIA Pharmaceuticals (ACAD)

TipRanksMar 12 08:40 ET

JMP Securities Cuts ACADIA Pharmaceuticals Price Target to $39 From $44, Maintains Market Outperform Rating

MT NewswiresMar 12 08:18 ET

ACADIA Pharmaceuticals Analyst Ratings

BenzingaMar 12 05:25 ET

Maintaining Hold on ACADIA Pharmaceuticals Amid Clinical Setbacks and Valuation Adjustments

TipRanksMar 12 05:20 ET

Analysts Are Bullish on These Healthcare Stocks: ACADIA Pharmaceuticals (ACAD), Larimar Therapeutics (LRMR)

TipRanksMar 12 00:40 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: ACADIA Pharmaceuticals (ACAD) and Enhabit, Inc (EHAB)

TipRanksMar 11 01:20 ET

RBC Capital Reaffirms Their Buy Rating on ACADIA Pharmaceuticals (ACAD)

TipRanksMar 8 07:26 ET

ACADIA Pharmaceuticals (ACAD) Gets a Buy From TD Cowen

TipRanksMar 7 07:15 ET

ACADIA Pharmaceuticals Analyst Ratings

BenzingaMar 1 07:48 ET

ACADIA Pharmaceuticals: Resilient Performance and Growth Potential Affirm Buy Rating

TipRanksMar 1 01:01 ET